期刊
CONTRACEPTION
卷 79, 期 2, 页码 111-116出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.contraception.2008.09.002
关键词
Contraception; Insulin; Metabolism; Progesterone; Chlormadinone acetate; Desogestrel
资金
- Department of obstetrics and Gynecology, University of Modena
Background: Second-generation and third-generation oral contraceptives containing 30 mcg or more of ethinylestradiol (EE) decrease insulin sensitivity (SI). In this study, we investigated whether SI is decreased by contraceptives containing lower closes EE or by progestins with antiandrogenic properties. Study Design: Twenty-eight Young healthy women were randomly allocated to receive 20 mcg of EE and 150 mcg, of desogestrel (DSG) (n=14) or 30 mcg of EE and 2 mg of chlormadinone acetate (CMA) (n=14) for 6 months. SI and glucose utilization independent of insulin (Sg) were investigated by the minimal model method. Lipid modifications were also analyzed. Results: SI decreased with EE/DSG (7.09 +/- 1.4 vs. 4.30 +/- 0.91; p=.04; n=12), but not with EE/CMA (5.79 +/- 0.93 vs. 6.79 +/- 1.1; p=.48; n=12). SI modifications observed in the two groups were significantly different (-2.79 +/- 1.15 vs. 1.0 +/- 1.38; p=.05), Sg did not vary with either treatment. The response of C-peptide to glucose increased, but significantly so only with EE/CMA (p=.01). The C-peptide/insulin response increased with both EE/DSG (p=.05) and EE/CMA (p=.04). High-density lipoprotein (HDL) cholesterol (p=.02) and triglycerides (p=.02 and p=.01) increased in both groups, but HDL/low-density lipoprotein cholesterol (p=.02), apoprotein A1 (Apo-A1) (p=.04) and Apo-A1/apoprotein B (p=.048) increased significantly only with EE/CMA. Conclusions: The present study confirms that DSG, even when associated with low EE dose, decreases SI. By contrast, EE/CMA does not deteriorate SI and induces a favorable lipid profile. (C) 2009 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据